Ornithine deficiency in the arginase double knockout mouse

被引:56
作者
Deignan, Joshua L.
Livesay, Justin C.
Yoo, Paul K.
Goodman, Stephen I.
O'Brien, William E.
Iyer, Ramaswamy K.
Cederbaum, Stephen D.
Grody, Wayne W. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Mental Retardat Res Ctr, Los Angeles, CA USA
[6] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA
[7] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
关键词
arginase; ornithine; arginine; knockout; hyperargininemia; hyperammonemia; ornithine aminotransferase;
D O I
10.1016/j.ymgme.2006.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Knockout mouse models have been created to study the consequences of deficiencies in arginase AI and AII, both individually and combined. The At knockout animals die by 14 days of age from hyperammonemia, while the All knockout has no obvious phenotype. The double knockout (AI(-/-)/AII(-/-)) exhibits the phenotype of the AI-deficient mice, with the additional absence of All not exacerbating the observed phenotype of the AI knockout animals. Plasma amino acid measurements in the double knockout have shown arginine levels increased roughly 100-fold and ornithine decreased roughly 10-fold as compared to wildtype. Liver ornithine levels were reduced to 2% of normal in the double knockout with arginine very highly elevated. Arginine and ornithine were also altered in other tissues in the double knockout mice, such as kidney, brain, and small intestine. This is the first demonstration that the fatal hyperammonemia in the AI knockout mouse is almost certainly due to ornithine deficiency, the amino acid needed to drive the urea cycle. Others have shown that the expression of ornithine aminotransferase (OAT) rapidly decreases in the intestine at the same age when the AI-deficient animals die, indicating that this enzyme is critical to the maintenance of ornithine homeostasis, at least at this early stage of mouse development. Although most human AI-deficient patients have no symptomatic hyperammonemia at birth, it is possible that clinically significant ornithine deficiency is already present. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 31 条
[11]  
GRODY WW, 1993, HUM GENET, V91, P1
[12]   HETEROGENEITY OF ARGINASES IN RAT TISSUES [J].
HERZFELD, A ;
RAPER, SM .
BIOCHEMICAL JOURNAL, 1976, 153 (02) :469-478
[13]  
HIRAYASU Y, 1990, JPN J PSYCHIAT NEUR, V44, P448
[14]   Mouse model for human arginase deficiency [J].
Iyer, RK ;
Yoo, PK ;
Kern, RM ;
Rozengurt, N ;
Tsoa, R ;
O'Brien, WE ;
Yu, H ;
Grody, WW ;
Cederbaum, SD .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (13) :4491-4498
[15]   THE PATHOBIOCHEMISTRY OF UREMIA AND HYPERARGININEMIA FURTHER DEMONSTRATES A METABOLIC RELATIONSHIP BETWEEN UREA AND GUANIDINOSUCCINIC ACID [J].
MARESCAU, B ;
DEDEYN, PP ;
QURESHI, IA ;
DEBROE, ME ;
ANTONOZZI, I ;
CEDERBAUM, SD ;
CERONE, R ;
CHAMOLES, N ;
GATTI, R ;
KANG, SS ;
LAMBERT, M ;
POSSEMIERS, I ;
SNYDERMAN, SE ;
YOSHINO, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (09) :1021-1024
[16]   GUANIDINO COMPOUND ANALYSIS AS A COMPLEMENTARY DIAGNOSTIC PARAMETER FOR HYPERARGININEMIA - FOLLOW-UP OF GUANIDINO COMPOUND LEVELS DURING THERAPY [J].
MARESCAU, B ;
DEDEYN, PP ;
LOWENTHAL, A ;
QURESHI, IA ;
ANTONOZZI, I ;
BACHMANN, C ;
CEDERBAUM, SD ;
CERONE, R ;
CHAMOLES, N ;
COLOMBO, JP ;
HYLAND, K ;
GATTI, R ;
KANG, SS ;
LETARTE, J ;
LAMBERT, M ;
MIZUTANI, N ;
POSSEMIERS, I ;
REZVANI, I ;
SNYDERMAN, SE ;
TERHEGGEN, HG ;
YOSHINO, M .
PEDIATRIC RESEARCH, 1990, 27 (03) :297-303
[17]   GUANIDINO COMPOUNDS IN PLASMA, URINE AND CEREBROSPINAL-FLUID OF HYPERARGININEMIC PATIENTS DURING THERAPY [J].
MARESCAU, B ;
QURESHI, IA ;
DEDEYN, P ;
LETARTE, J ;
RYBA, R ;
LOWENTHAL, A .
CLINICA CHIMICA ACTA, 1985, 146 (01) :21-27
[18]   PROPERTIES AND ANALYSIS OF A STABLE DERIVATIVE OF PYRROLINE-5-CARBOXYLIC ACID FOR USE IN METABOLIC STUDIES [J].
MEZL, VA ;
KNOX, WE .
ANALYTICAL BIOCHEMISTRY, 1976, 74 (02) :430-440
[19]   GUANIDINO COMPOUNDS IN HYPERARGININEMIA [J].
MIZUTANI, N ;
HAYAKAWA, C ;
OHYA, Y ;
WATANABE, K ;
WATANABE, Y ;
MORI, A .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 153 (03) :197-205
[20]   Human type II arginase: Sequence analysis and tissue-specific expression [J].
Morris, SM ;
Bhamidipati, D ;
KepkaLenhart, D .
GENE, 1997, 193 (02) :157-161